205 related articles for article (PubMed ID: 8066565)
1. Value of DNA analysis in addition to cytological testing in the diagnosis of malignant pleural effusions.
Rodríguez de Castro F; Molero T; Acosta O; Julià-Serdà G; Caminero J; Cabrera P; Carrillo T
Thorax; 1994 Jul; 49(7):692-4. PubMed ID: 8066565
[TBL] [Abstract][Full Text] [Related]
2. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
Huang MS; Tsai MS; Hwang JJ; Wang TH
Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
[TBL] [Abstract][Full Text] [Related]
3. Routine DNA cytometry of benign and malignant pleural effusions by means of the remote quantitation server Euroquant: a prospective study.
Kayser K; Blum S; Beyer M; Haroske G; Kunze KD; Meyer W
J Clin Pathol; 2000 Oct; 53(10):760-4. PubMed ID: 11064669
[TBL] [Abstract][Full Text] [Related]
4. Role of DNA flow cytometry and image cytometry on effusion fluid.
Saha I; Dey P; Vhora H; Nijhawan R
Diagn Cytopathol; 2000 Feb; 22(2):81-5. PubMed ID: 10649516
[TBL] [Abstract][Full Text] [Related]
5. [Relative DNA content and cycle distribution of cells in pleural effusions studied by flow-cytometry].
Shen C; Ye YQ; Lou WT
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Apr; 17(2):90-2, 126. PubMed ID: 7994775
[TBL] [Abstract][Full Text] [Related]
6. Static DNA cytometry as a diagnostic aid in effusion cytology: II. DNA aneuploidy for identification of neoplastic cells in equivocal effusions.
Motherby H; Nadjari B; Remmerbach T; Marcy T; Pomjanskaja N; Müller W; Knops K; Häussinger D; Strauer BE; Böcking A
Anal Quant Cytol Histol; 1998 Jun; 20(3):162-8. PubMed ID: 9642442
[TBL] [Abstract][Full Text] [Related]
7. Cytology and flow cytometry of malignant effusions of multiple myeloma.
Palmer HE; Wilson CS; Bardales RH
Diagn Cytopathol; 2000 Mar; 22(3):147-51. PubMed ID: 10679993
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of DNA, RNA and proliferating cell nuclear antigen examination in malignant pleural effusions by flow cytometry].
Wang LX; Chen WX; Wu J; Chen SX; Huang XY; Chen YF
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):804-7. PubMed ID: 17327081
[TBL] [Abstract][Full Text] [Related]
9. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.
Sriram KB; Relan V; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Bowman RV; Fong KM
BMC Cancer; 2012 Sep; 12():428. PubMed ID: 23009708
[TBL] [Abstract][Full Text] [Related]
10. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
Lee WY
Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
[TBL] [Abstract][Full Text] [Related]
11. Characterization of pleural effusions by flow-cytometric DNA analysis.
Høstmark J; Vigander T; Skaarland E
Eur J Respir Dis; 1985 May; 66(5):315-9. PubMed ID: 4018184
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.
Han J; Cao S; Zhang K; Zhao G; Xin Y; Dong Q; Yan Y; Cui J
J Cardiothorac Surg; 2012 Nov; 7():121. PubMed ID: 23148562
[TBL] [Abstract][Full Text] [Related]
13. Benign and malignant cells in effusions: diagnostic value of image DNA cytometry in comparison to cytological analysis.
Decker D; Stratmann H; Springer W; Schwering H; Varnai N; Bollmann R
Pathol Res Pract; 1998; 194(11):791-5. PubMed ID: 9842638
[TBL] [Abstract][Full Text] [Related]
14. Measurement of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions.
Hedley DW; Philips J; Rugg CA; Taylor IW
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):749-52. PubMed ID: 6540177
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite alterations and cell-free DNA analysis: could they increase the cytology sensitivity in the diagnosis of malignant pleural effusion?
Carpagnano GE; Costantino E; Palladino GP; Lacedonia D; Martinelli D; Orlando S; Foschino-Barbaro MP
Rejuvenation Res; 2012 Jun; 15(3):265-73. PubMed ID: 22551519
[TBL] [Abstract][Full Text] [Related]
16. Complementary value of DNA flow cytometry and image morphometry in detection of malignant cells in effusion fluids.
Bisht B; Handa U; Mohan H; Lehl SS
Malays J Pathol; 2014 Aug; 36(2):83-90. PubMed ID: 25194530
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.
Dietrich D; Jung M; Puetzer S; Leisse A; Holmes EE; Meller S; Uhl B; Schatz P; Ivascu C; Kristiansen G
PLoS One; 2013; 8(12):e84225. PubMed ID: 24386354
[TBL] [Abstract][Full Text] [Related]
18. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
19. Image cytometry: an aid for cytological diagnosis of pleural effusions.
Osterheld MC; Liette C; Anca M
Diagn Cytopathol; 2005 Mar; 32(3):173-6. PubMed ID: 15690335
[TBL] [Abstract][Full Text] [Related]
20. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.
Maskell NA; Gleeson FV; Davies RJ
Lancet; 2003 Apr; 361(9366):1326-30. PubMed ID: 12711467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]